| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab129464-10μl |
10μl |
现货  |
| |
| Ab129464-50μl |
50μL |
现货 |
| |
| Ab129464-100μl |
100μL |
现货 |
| |
| Ab129464-1ml |
1ml |
期货 |
|
| 产品名称 | STAT5a Antibody |
|---|---|
| 别名 | 信号转导和转录激活因子5a多克隆抗体 | STAT5a 抗体 |
| 英文别名 | Mammary gland factor antibody | MGF antibody | Signal transducer and activator of transcription 5A antibody | STA5A_HUMAN antibody | STAT 5 antibody | STAT 5A antibody | STAT5 antibody | STAT5A antibody | MGF | signal transducer and activator of transcrip |
| 规格或纯度 | 无载体, ExactAb™, 已验证, 高性能, 见COA |
| 宿主种属 | 兔(Rabbit) |
| 特异性 | STAT5a |
| 种属反应性 | 人(Human),小鼠(Mouse),猪(Pig) |
| 免疫原 | Recombinant STAT5a expressed in E.coli (AA 673-773) |
| 阳性对照 | WB: MOLT-4 and K562 cell lysates. IHC: Human lymph node tissue. |
| 偶联 | Unconjugated |
| 克隆类型 | 多克隆抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Rabbit IgG |
| SDS-PAGE | 150 kDa |
| 纯化方法 | Antigen affinity purified and Protein A purified |
| 物理外观 | Liquid |
| 储存缓冲液 | 10 mM PBS, 50% Glycerol, 0.02% Sodium azide, pH7.4 |
| 防腐剂 | 0.02% Sodium azide |
| 浓度 | 见COA |
| 储存温度 | -20°C储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 4℃ 短期储存（1-2 周）。-20℃长期保存（24 个月）。收货后建议分装。避免冷冻/解冻循环。 |
| 分子类型 | 抗体 |
STAT5a Antibody (Ab129464) - Western Blot
All lanes: STAT5a Antibody (Ab129464) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/40000 dilution
Predicted band size: 90 kDa
Observed band size: 90 kDa
Exposure time: 24.2 s
STAT5a Antibody (Ab129464) - IHC
DAB staining on IHC
Sample: Human Lymph node Tissue
Primary Ab: 20 μg/mL STAT5a Antibody (Ab129464)
Second Ab: 2 µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 应用名称 | 稀释比例 |
|---|---|
| IHC | 5-20 µg/mL |
| WB |
0.01-2 µg/mL
|
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
 ZJ24F1011794 |
分析证书 | 24-10-11 | Ab129464 |
| ZJ23F1001318 |
分析证书 | 23-10-18 | Ab129464 |
| ZJ23F1001317 |
分析证书 | 23-10-18 | Ab129464 |
| 1. Ioannidis S, Lamb ML, Wang T, Almeida L, Block MH, Davies AM, Peng B, Su M, Zhang HJ, Hoffmann E et al.. (2011) Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak/Stat pathway.. J Med Chem, 54 (1): (262-76). [PMID:21138246] |
| 2. Galkin AV, Melnick JS, Kim S, Hood TL, Li N, Li L, Xia G, Steensma R, Chopiuk G, Jiang J et al.. (2007) Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.. Proc Natl Acad Sci USA, 104 (1): (270-5). [PMID:17185414] |
| 3. Changelian PS, Flanagan ME, Ball DJ, Kent CR, Magnuson KS, Martin WH, Rizzuti BJ, Sawyer PS, Perry BD, Brissette WH et al.. (2003) Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.. Science, 302 (5646): (875-8). [PMID:14593182] |
| 4. Jiang JK, Ghoreschi K, Deflorian F, Chen Z, Perreira M, Pesu M, Smith J, Nguyen DT, Liu EH, Leister W, Costanzi S, O'Shea JJ, Thomas CJ.. (2008) Examining the chirality, conformation and selective kinase inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550).. J Med Chem, 51 (24): (8012-8018). [PMID:19053756] [10.1021/jm801142b] |
| 5. Wilson LJ, Malaviya R, Yang C, Argentieri R, Wang B, Chen X, Murray WV, Cavender D.. (2009) Synthetic staurosporines via a ring closing metathesis strategy as potent JAK3 inhibitors and modulators of allergic responses.. Bioorg Med Chem Lett, 19 (12): (3333-3338). [PMID:19427203] [10.1016/j.bmcl.2009.04.039] |
| 6. Ren X, Duan L, He Q, Zhang Z, Zhou Y, Wu D, Pan J, Pei D, Ding K, Ding K.. (2010) Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway.. ACS Med Chem Lett, 1 (9): (454-459). [PMID:24900231] [10.1021/ml100146z] |
| 7. Mandal PK, Gao F, Lu Z, Ren Z, Ramesh R, Birtwistle JS, Kaluarachchi KK, Chen X, Bast RC, Liao WS, McMurray JS.. (2011) Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.. J Med Chem, 54 (10): (3549-3563). [PMID:21486047] [10.1021/jm2000882] |
| 8. Kumar A, Shah BA, Singh S, Hamid A, Singh SK, Sethi VK, Saxena AK, Singh J, Taneja SC.. (2012) Acyl derivatives of boswellic acids as inhibitors of NF-κB and STATs.. Bioorg Med Chem Lett, 22 (1): (431-435). [PMID:22123322] [10.1016/j.bmcl.2011.10.112] |
| 9. Page BD, Khoury H, Laister RC, Fletcher S, Vellozo M, Manzoli A, Yue P, Turkson J, Minden MD, Gunning PT.. (2012) Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.. J Med Chem, 55 (3): (1047-1055). [PMID:22148584] [10.1021/jm200720n] |
| 10. Page BD, Croucher DC, Li ZH, Haftchenary S, Jimenez-Zepeda VH, Atkinson J, Spagnuolo PA, Wong YL, Colaguori R, Lewis AM, Schimmer AD, Trudel S, Gunning PT.. (2013) Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against multiple myeloma.. J Med Chem, 56 (18): (7190-7200). [PMID:23968501] [10.1021/jm3017255] |
| 11. Haftchenary S, Luchman HA, Jouk AO, Veloso AJ, Page BD, Cheng XR, Dawson SS, Grinshtein N, Shahani VM, Kerman K, Kaplan DR, Griffin C, Aman AM, Al-Awar R, Weiss S, Gunning PT.. (2013) Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma.. ACS Med Chem Lett, 4 (11): (1102-1107). [PMID:24900612] [10.1021/ml4003138] |
| 12. Chen H, Guan Y, Yuan G, Zhang Q, Jing N.. (2014) A perylene derivative regulates HIF-1α and Stat3 signaling pathways.. Bioorg Med Chem, 22 (4): (1496-1505). [PMID:24485121] [10.1016/j.bmc.2013.10.018] |
| 13. Romagnoli R, Baraldi PG, Prencipe F, Lopez-Cara C, Rondanin R, Simoni D, Hamel E, Grimaudo S, Pipitone RM, Meli M, Tolomeo M.. (2016) Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation.. Eur J Med Chem, 108 (39-52). [PMID:26629859] [10.1016/j.ejmech.2015.11.022] |
| 14. Juen L, Brachet-Botineau M, Parmenon C, Bourgeais J, Hérault O, Gouilleux F, Viaud-Massuard MC, Prié G.. (2017) New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias.. J Med Chem, 60 (14): (6119-6136). [PMID:28654259] [10.1021/acs.jmedchem.7b00369] |
| 15. Kim HS, Kim T, Ko H, Lee J, Kim YS, Suh YG.. (2017) Identification of galiellalactone-based novel STAT3-selective inhibitors with cytotoxic activities against triple-negative breast cancer cell lines.. Bioorg Med Chem, 25 (19): (5032-5040). [PMID:28705432] [10.1016/j.bmc.2017.06.036] |
| 16. Berg A, Berg T.. (2017) A small-molecule screen identifies the antitrypanosomal agent suramin and analogues NF023 and NF449 as inhibitors of STAT5a/b.. Bioorg Med Chem Lett, 27 (15): (3349-3352). [PMID:28624143] [10.1016/j.bmcl.2017.06.012] |
| 17. Guo J, Yu W, Cai G, Zhang W, Li S, Zhu J, Song D, Kong L.. (2018) Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors.. Eur J Med Chem, 151 (752-764). [PMID:29674294] [10.1016/j.ejmech.2018.03.053] |
| 18. Zhou H, Bai L, Xu R, Zhao Y, Chen J, McEachern D, Chinnaswamy K, Wen B, Dai L, Kumar P, Yang CY, Liu Z, Wang M, Liu L, Meagher JL, Yi H, Sun D, Stuckey JA, Wang S.. (2019) Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.. J Med Chem, 62 (24): (11280-11300). [PMID:31747516] [10.1021/acs.jmedchem.9b01530] |
| 19. Huang MR, Hsu YL, Lin TC, Cheng TJ, Li LW, Tseng YW, Chou YS, Liu JH, Pan SH, Fang JM, Wong CH.. (2019) Structure-guided development of purine amide, hydroxamate, and amidoxime for the inhibition of non-small cell lung cancer.. Eur J Med Chem, 181 (111551-111551). [PMID:31376567] [10.1016/j.ejmech.2019.07.054] |
| 20. Kaoud TS,Mohassab AM,Hassan HA,Yan C,Van Ravenstein SX,Abdelhamid D,Dalby KN,Abdel-Aziz M. (2020) NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth.. Eur J Med Chem, 186 (111885-111885). [PMID:31784187] [10.1016/j.ejmech.2019.111885] |
| 21. Schoepf AM,Salcher S,Obexer P,Gust R. (2020) Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cells.. Eur J Med Chem, 195 (112258-112258). [PMID:32272420] [10.1016/j.ejmech.2020.112258] |
| 22. Schoepf AM, Salcher S, Obexer P, Gust R.. (2021) Tackling resistance in chronic myeloid leukemia: Novel cell death modulators with improved efficacy.. Eur J Med Chem, 216 (113285-113285). [PMID:33662676] [10.1016/j.ejmech.2021.113285] |
| 23. Hou, J J, Schindler, U U, Henzel, W J WJ, Wong, S C SC and McKnight, S L SL.. (1995) Identification and purification of human Stat proteins activated in response to interleukin-2.. Immunity, [PMID:7719937] |
| 24. Litterst, Claudia M CM, Kliem, Stefanie S, Marilley, Dominique D and Pfitzner, Edith E.. (2003) NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the alpha-helical region of the STAT5 transactivation domain.. The Journal of biological chemistry, (14): [PMID:12954634] |
| 25. Taketani, Takeshi T and 9 more authors.. (2004) FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.. Blood, (1): [PMID:14504097] |
| 26. Rönnstrand, L L.. (2004) Signal transduction via the stem cell factor receptor/c-Kit.. Cellular and molecular life sciences : CMLS, [PMID:15526160] |
| 27. Williams, Christopher C CC and 6 more authors.. (2004) The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone.. The Journal of cell biology, (8): [PMID:15534001] |
| 28. Martens, Nele N and 5 more authors.. (2005) Suppressor of cytokine signaling 7 inhibits prolactin, growth hormone, and leptin signaling by interacting with STAT5 or STAT3 and attenuating their nuclear translocation.. The Journal of biological chemistry, (8): [PMID:15677474] |
| 29. Zody, Michael C MC and 73 more authors.. (2006) DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.. Nature, (20): [PMID:16625196] |
| 30. Chaix, Amandine A and 5 more authors.. (2011) Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells.. The Journal of biological chemistry, (25): [PMID:21135090] |
首页
400-620-6333
